VELTASSA

Peak

patiromer

NDAORALPOWDER

Approved

Oct 2015

Lifecycle

Peak

Competitive Pressure

0/100

Mechanism of Action

Potassium Ion Binding Activity

Pharmacologic Class:

Potassium Binder

Loss of Exclusivity

LOE Date

Oct 8, 2033

92 months away

Patent Expiry

Oct 8, 2033

Exclusivity Expiry

Oct 2, 2026

Patent Records (5)

Patent #	Expiry	Type	Use Code
8216560	Mar 14, 2027		U-1766
8282913	May 29, 2027	Product	—
8147873	Jun 20, 2028	Product	—
8337824	May 29, 2030	Substance	U-1766
11123363	Oct 8, 2033		U-1766

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers